The SOS response master regulator LexA is associated with sporulation, motility and biofilm formation in clostridium difficile

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Walter, Beata M ^a   Cartman, Stephen T ^b,f   Minton, Nigel P ^b   Butala, Matej ^c   Rupnik, Maja ^a,d,e  

^a National Laboratory for Health   (Slovenia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d UNIVERSITY OF MARIBOR   (Slovenia)

^e Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins   (Slovenia)

^f Invista   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; LEVOFLOXACIN; METRONIDAZOLE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; LEXA PROTEIN, BACTERIA; SERINE PROTEINASE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CELL DIVISION; CELL MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA DAMAGE; DNA REPAIR; GENE FUNCTION; GENE MUTATION; LEXA GENE; MUTAGENESIS; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PHENOTYPE; RECA GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOS GENE; SPOROGENESIS; WILD TYPE; BACTERIAL SPORE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION; PHYSIOLOGY; SOS RESPONSE (GENETICS);

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOFILMS; CELL DIVISION; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; GENE EXPRESSION REGULATION, BACTERIAL; LEVOFLOXACIN; MUTATION; SERINE ENDOPEPTIDASES; SOS RESPONSE (GENETICS); SPORES, BACTERIAL;

EID: 84956880530     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144763     Document Type: Article

References (58)

1. Erill I, Campoy S, Barbe J. Aeons of distress: An evolutionary perspective on the bacterial SOS response. FEMS Microbiol Rev. 2007; 31(6):637-56. doi: 10.1111/j.1574-6976.2007.00082.x
2. Butala M, Žgur-Bertok D, Busby SJ. The bacterial LexA transcriptional repressor. Cell Mol Life Sci. 2009; 66(1):82-93. doi: 10.1007/s00018-008-8378-6
3. Cox MM. Regulation of bacterial RecA protein function. Critical reviews in biochemistry and molecular biology. 2007; 42(1):41-63. doi: 10.1080/10409230701260258
4. Johnston JL, Sloan J, Fyfe JA, Davies JK, Rood JI. The recA gene from Clostridium perfringens is induced by methyl methanesulphonate and contains an upstream Cheo box. Microbiology. 1997; 143 (Pt 3):885-90.
5. Nuyts S, Van Mellaert L, Barbe S, Lammertyn E, Theys J, Landuyt W, et al. Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol. 2001; 67 (10):4464-70.
6. Quinones M, Kimsey HH, Waldor MK. LexA cleavage is required for CTX prophage induction. Mol Cell. 2005; 17(2):291-300. doi: 10.1016/j.molcel.2004.11.046
7. Žgur-Bertok D. Regulating colicin synthesis to cope with stress and lethality of colicin production. Biochem Soc Trans. 2012; 40(6):1507-11. doi: 10.1042/BST20120184
8. Jerman B, Butala M, Žgur-Bertok D. Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli. Antimicrob Agents Chemother. 2005; 49(7):3087-90. doi: 10.1128/AAC.49.7. 3087-3090.2005
9. Chellappa ST, Maredia R, Phipps K, Haskins WE, Weitao T. Motility of Pseudomonas aeruginosa contributes to SOS-inducible biofilm formation. Res Microbiol. 2013; 164(10):1019-27. doi: 10.1016/j. resmic.2013.10.001
10. Vlasic I, Mertens R, Seco EM, Carrasco B, Ayora S, Reitz G, et al. Bacillus subtilis RecA and its accessory factors, RecF, RecO, RecR and RecX, are required for spore resistance to DNA double-strand break. Nucleic Acids Res. 2014; 42(4):2295-307. doi: 10.1093/nar/gkt1194
11. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009; 7(7):526-36. doi: 10.1038/nrmicro2164
12. Walter BM, Rupnik M, Hodnik V, Anderluh G, Dupuy B, Paulic N, et al. The LexA regulated genes of the Clostridium difficile. BMC Microbiol. 2014; 14(1):88. doi: 10.1186/1471-2180-14-88
13. Pettit LJ, Browne HP, Yu L, Smits WK, Fagan RP, Barquist L, et al. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics. 2014; 15:160. doi: 10.1186/1471-2164-15-160
14. Chong PM, Lynch T, McCorrister S, Kibsey P, Miller M, Gravel D, et al. Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole. PloS One. 2014; 9(1):e82622. doi: 10. 1371/journal.pone.0082622
15. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, et al. The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods. 2010; 80(1):49-55. doi: 10.1016/j. mimet.2009.10.018
16. Bouillaut L, McBride SM, Sorg JA. Genetic manipulation of Clostridium difficile. Curr Protoc Microbiol. 2011;Chapter 9:Unit 9A 2. doi: 10.1002/9780471729259.mc09a02s20
17. Heap JT, Pennington OJ, Cartman ST, Minton NP. A modular system for Clostridium shuttle plasmids. J Microbiol Methods. 2009; 78(1):79-85. doi: 10.1016/j.mimet.2009.05.004
18. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. The ClosTron: A universal gene knockout system for the genus Clostridium. J Microbiol Methods. 2007; 70(3):452-64. doi: 10.1016/j.mimet. 2007.05.021
19. Zidaric V, Pardon B, Dos Vultos T, Deprez P, Brouwer MS, Roberts AP, et al. Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm. Appl Environ Microbiol. 2012; 78(24):8515-22. doi: 10.1128/AEM.02185-12
20. Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmee M, et al. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of Clostridium difficile infections in Europe. J Med Microbiol. 2008; 57(Pt 6):784-9. doi: 10.1099/jmm.0.47738-0
21. Keessen EC, Hensgens MP, Spigaglia P, Barbanti F, Sanders IM, Kuijper EJ, et al. Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078. Antimicrob Resist Infect Control. 2013; 2:14. doi: 10.1186/2047-2994-2-14
22. Lachowicz D, Pituch H, Obuch-Woszczatynski P. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Anaerobe. 2015; 31:37-41. doi: 10.1016/j.anaerobe.2014.09.004
23. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. Available: http://www.eucast.org.
24. Metcalf D, Sharif S, Weese JS. Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe. 2010; 16(4):439-43. doi: 10.1016/j.anaerobe.2010.06.007
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8.
26. Deneve C, Delomenie C, Barc MC, Collignon A, Janoir C. Antibiotics involved in Clostridium difficileassociated disease increase colonization factor gene expression. J Med Microbiol. 2008; 57(Pt 6):732-8. doi: 10.1099/jmm.0.47676-0
27. Burns DA, Heap JT, Minton NP. SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. J Bacteriol. 2010; 192(3):657-64. doi: 10.1128/JB.01209-09
28. Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, et al. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013; 195(3):545-55. doi: 10.1128/JB.01980-12
29. Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP. Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production. Appl Environ Microbiol. 2012; 78(13):4683-90. doi: 10.1128/AEM.00249-12
30. Godoy V, G., Beuning P, J., Walker G, C. LexA regulatory system. In: Lennarz WJ, Lane WD, editors. Encyclopedia of Biological Chemistry. San Diego: Elsevier; 2004. pp.546-50.
31. Buchholz M, Nahrstedt H, Pillukat MH, Deppe V, Meinhardt F. yneA mRNA instability is involved in temporary inhibition of cell division during the SOS response of Bacillus megaterium. Microbiol. 2013; 159 (Pt 8):1564-74. doi: 10.1099/mic.0.064766-0
32. Kawai Y, Moriya S, Ogasawara N. Identification of a protein, YneA, responsible for cell division suppression during the SOS response in Bacillus subtilis. Mol Microbiol. 2003; 47(4):1113-22.
33. Roth V. Doubling time online calculator. 2006. Available: http://www.doubling-Time.com/compute.php.
34. Sagar S, Kumar R. Role of SOS Response in Bacterial Drug Resistance. Int J Pharm Sci Rev Res. 2014; 25(1):102-5.
35. Singh R, Ledesma KR, Chang KT, Tam VH. Impact of recA on levofloxacin exposure-related resistance development. Antimicrob Agents Chemother. 2010; 54(10):4262-8. doi: 10.1128/AAC.00168-10
36. Spigaglia P, Barbanti F, Louie T, Barbut F, Mastrantonio P. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob Agents Chemother. 2009; 53(6):2463-8. doi: 10.1128/AAC.01252-08
37. Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014; 22(8):438-45. doi: 10.1016/j.tim. 2014.04.007
38. Baharoglu Z, Krin E, Mazel D. RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae. PLoS Genet. 2013; 9(4):e1003421. doi: 10.1371/journal.pgen. 1003421
39. Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, Hughes D, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011; 7(7):e1002158. doi: 10.1371/journal.ppat. 1002158
40. Burns DA, Heeg D, Cartman ST, Minton NP. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PloS One. 2011; 6(9):e24894. doi: 10.1371/journal.pone. 0024894
41. Au N, Kuester-Schoeck E, Mandava V, Bothwell LE, Canny SP, Chachu K, et al. Genetic composition of the Bacillus subtilis SOS system. J Bacteriol. 2005; 187(22):7655-66. doi: 10.1128/JB.187.22.7655-7666.2005
42. Cowan AE, Koppel DE, Setlow B, Setlow P. A soluble protein is immobile in dormant spores of Bacillus subtilis but is mobile in germinated spores: implications for spore dormancy. Proc Natl Acad Sci U S A. 2003; 100(7):4209-14. doi: 10.1073/pnas.0636762100
43. Rowland SL, Burkholder WF, Cunningham KA, Maciejewski MW, Grossman AD, King GF. Structure and mechanism of action of Sda, an inhibitor of the histidine kinases that regulate initiation of sporulation in Bacillus subtilis. Mol Cell. 2004; 13(5):689-701.
44. Edwards AN, McBride SM. Initiation of sporulation in Clostridium difficile: A twist on the classic model. FEMS Microbiol Lett. 2014; 358(2):110-8. doi: 10.1111/1574-6968.12499
45. Gotoh H, Kasaraneni N, Devineni N, Dallo SF, Weitao T. SOS involvement in stress-inducible biofilm formation. Biofouling. 2010; 26(5):603-11. doi: 10.1080/08927014.2010.501895
46. Fang A, Gerson DF, Demain AL. Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests. Proc Natl Acad Sci U S A. 2009; 106(32):13225-9. doi: 10.1073/pnas.0906425106
47. Drummond LJ, Smith DG, Poxton IR. Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile. J Med Microbiol. 2003; 52(Pt 12):1033-8.
48. Pultz NJ, Donskey CJ. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. Antimicrob Agents Chemother. 2005; 49(8):3529-32. doi: 10. 1128/AAC.49.8.3529-3532.2005
49. Aldape MJ, Packham AE, Nute DW, Bryant AE, Stevens DL. Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile. J Med Microbiol. 2013; 62(Pt 5):741-7. doi: 10. 1099/jmm.0.056218-0
50. Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol. 1998; 27(1):107-20.
51. Mani N, Dupuy B. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A. 2001; 98(10):5844-9. doi: 10.1073/pnas.101126598
52. Lynch T, Chong P, Zhang J, Hizon R, Du T, Graham MR, et al. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate. PloS One. 2013; 8(1):e53757. doi: 10.1371/journal. pone.0053757
53. Mathur H, O'Connor PM, Hill C, Cotter PD, Ross RP. Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations. Antimicrob Agents Chemother. 2013; 57(6):2882-6. doi: 10.1128/AAC.00261-13
54. Moura I, Spigaglia P, Barbanti F, Mastrantonio P. Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes. J Antimicrob Chemother. 2013; 68(2):362-5. doi: 10.1093/jac/dks420
55. Tenover FC, Tickler IA, Persing DH. Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother. 2012; 56(6):2929-32. doi: 10.1128/AAC.00220-12
56. Pelaez T, Cercenado E, Alcala L, Marin M, Martin-Lopez A, Martinez-Alarcon J, et al. Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol. 2008; 46(9):3028-32. doi: 10. 1128/JCM.00524-08
57. Da Re S, Garnier F, Guerin E, Campoy S, Denis F, Ploy MC. The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO reports. 2009; 10(8):929-33.
58. Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plesiat P, et al. Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. PLoS pathogens. 2012; 8(6):e1002778. doi: 10.1371/journal.ppat.1002778